BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 11146559)

  • 21. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
    Pierce AM; Fisher SM; Conti CJ; Johnson DG
    Oncogene; 1998 Mar; 16(10):1267-76. PubMed ID: 9546428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas.
    Divan A; Lawry J; Dunsmore IR; Parsons MA; Royds JA
    Cancer Res; 2001 Apr; 61(7):3157-63. PubMed ID: 11306502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
    Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the E2F-1/DP-1 transcription factor in murine development.
    Tevosian SG; Paulson KE; Bronson R; Yee AS
    Cell Growth Differ; 1996 Jan; 7(1):43-52. PubMed ID: 8788032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P130 and its truncated form mediate p53-induced cell cycle arrest in Rb(-/-) Saos2 cells.
    Gao CF; Ren S; Wang J; Zhang SL; Jin F; Nakajima T; Ikeda M; Tsuchida N
    Oncogene; 2002 Oct; 21(49):7569-79. PubMed ID: 12386819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The retinoblastoma gene: from its basic understanding as a signal mediator for growth and differentiation to its use in the treatment of cancer].
    Lee WH; Lee EY
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1368-80. PubMed ID: 9309128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
    Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP
    Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E2F-1-induced p53-independent apoptosis in transgenic mice.
    Holmberg C; Helin K; Sehested M; Karlström O
    Oncogene; 1998 Jul; 17(2):143-55. PubMed ID: 9674698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
    Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
    Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
    Hershko T; Chaussepied M; Oren M; Ginsberg D
    Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
    Orjuela M; Orlow I; Dudas M; Ponce-Castañeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
    Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apaf-1 is a transcriptional target for E2F and p53.
    Moroni MC; Hickman ES; Lazzerini Denchi E; Caprara G; Colli E; Cecconi F; Müller H; Helin K
    Nat Cell Biol; 2001 Jun; 3(6):552-8. PubMed ID: 11389439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microphthalmia due to p53-mediated apoptosis of anterior lens epithelial cells in mice lacking the CREB-2 transcription factor.
    Hettmann T; Barton K; Leiden JM
    Dev Biol; 2000 Jun; 222(1):110-23. PubMed ID: 10885750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1.
    Wang J; Helin K; Jin P; Nadal-Ginard B
    Cell Growth Differ; 1995 Oct; 6(10):1299-306. PubMed ID: 8845307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells.
    Vooijs M; te Riele H; van der Valk M; Berns A
    Oncogene; 2002 Jul; 21(30):4635-45. PubMed ID: 12096340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation.
    Xia X; Cheng A; Lessor T; Zhang Y; Hamburger AW
    J Cell Physiol; 2001 May; 187(2):209-17. PubMed ID: 11268000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myc lacks E2F1's ability to suppress skin carcinogenesis.
    Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
    Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A role for E2F1 in the induction of apoptosis during thymic negative selection.
    García I; Murga M; Vicario A; Field SJ; Zubiaga AM
    Cell Growth Differ; 2000 Feb; 11(2):91-8. PubMed ID: 10714765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.
    Meng RD; Phillips P; El-Deiry WS
    Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.